• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿5-羟色胺的荧光偏振免疫测定法

Fluorescence polarization immunoassay of urinary 5-hydroxy-3-indoleacetic acid.

作者信息

Brashear J, Zeitvogel C, Jackson J, Flentge C, Janulis L, Cantrell L, Schmidt B, Adamczyk M, Betebenner D, Vaughan K

机构信息

Abbott Laboratories Diagnostics Division, North Chicago, IL 60064.

出版信息

Clin Chem. 1989 Mar;35(3):355-9.

PMID:2465843
Abstract

Fluorescence polarization immunoassay of 5-hydroxy-3-indoleacetic acid in urine is described and compared with liquid chromatography (electrochemical detection) and colorimetry. Reports of in-house performance data and results of clinical trials are included to emphasize the usefulness of the assay for routine work.

摘要

本文描述了尿液中5-羟基-3-吲哚乙酸的荧光偏振免疫分析方法,并与液相色谱法(电化学检测)和比色法进行了比较。文中纳入了内部性能数据报告和临床试验结果,以强调该分析方法在常规工作中的实用性。

相似文献

1
Fluorescence polarization immunoassay of urinary 5-hydroxy-3-indoleacetic acid.尿5-羟色胺的荧光偏振免疫测定法
Clin Chem. 1989 Mar;35(3):355-9.
2
Liquid-chromatographic assay of urinary 5-hydroxy-3-indoleacetic acid, with electrochemical detection.采用电化学检测法对尿液中5-羟基-3-吲哚乙酸进行液相色谱分析。
Clin Chem. 1980 Jun;26(7):907-9.
3
Liquid-chromatographic determination of urinary 5-hydroxy-3-indoleacetic acid, with fluorescence detection.采用荧光检测的液相色谱法测定尿中5-羟基-3-吲哚乙酸。
Clin Chem. 1982 Jan;28(1):207-8.
4
Simultaneous automated high-performance liquid chromatographic determination of 5-hydroxy-3-indoleacetic acid and homovanillic acid in urine with fluorescence detection.
J Chromatogr. 1989 Oct 27;495:263-8. doi: 10.1016/s0378-4347(00)82630-4.
5
Urinary 4-hydroxy-3-methoxymandelic (vanillylmandelic) acid, 4-hydroxy-3-methoxyphenylacetic (homovanillic) acid, and 5-hydroxy-3-indoleacetic acid determined by liquid chromatography with electrochemical detection.
Clin Chem. 1983 May;29(5):876-8.
6
Liquid-chromatographic separation of urinary 5-hydroxy-3-indoleacetic acid, with measurement at 254 nm.采用液相色谱法分离尿中5-羟色胺酸,并在254nm波长处进行测定。
Clin Chem. 1980 Jun;26(7):910-2.
7
Determination of urinary 5-hydroxy-3-indoleacetic acid by an automated HPLC method.采用自动高效液相色谱法测定尿中5-羟基-3-吲哚乙酸。
Biomed Chromatogr. 1989 May;3(3):114-7. doi: 10.1002/bmc.1130030305.
8
Simultaneous liquid chromatographic determination of vanillylmandelic acid, homovanillic acid, and 5-hydroxy-3-indoleacetic acid in urine, using isocratic elution and electrochemical detection.采用等度洗脱和电化学检测同时测定尿液中的香草扁桃酸、高香草酸和5-羟基-3-吲哚乙酸。
Biomed Chromatogr. 1987;2(3):115-9. doi: 10.1002/bmc.1130020307.
9
Colorimetric assay of urinary 5-hydroxy-3-indoleacetic acid.尿5-羟色胺酸的比色测定法。
Clin Biochem. 1982 Apr;15(2):106-8. doi: 10.1016/s0009-9120(82)96125-2.
10
Abbott's fluorescence polarization immunoassay for cyclosporine and metabolites compared with the Sandoz "Sandimmune" RIA.雅培公司的环孢素及其代谢物荧光偏振免疫分析法与山德士公司的“山地明”放射免疫分析法的比较。
Clin Chem. 1988 Sep;34(9):1904-6.

引用本文的文献

1
Comparison of Serum and Urinary 5-Hydroxyindoleacetic Acid as Biomarker for Neuroendocrine Neoplasms.血清和尿液5-羟吲哚乙酸作为神经内分泌肿瘤生物标志物的比较
J Endocr Soc. 2021 Jun 8;5(8):bvab106. doi: 10.1210/jendso/bvab106. eCollection 2021 Aug 1.
2
Urinary sampling for 5HIAA and metanephrines determination: revisiting the recommendations.用于5-羟吲哚乙酸(5HIAA)和间甲肾上腺素测定的尿液采样:重新审视相关建议。
Endocr Connect. 2017 Aug;6(6):R87-R98. doi: 10.1530/EC-17-0071. Epub 2017 May 31.
3
5-Hydroxyindoleacetic acid excretion following combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil plus ondansetron compared to ondansetron alone.
与单独使用昂丹司琼相比,环磷酰胺、表柔比星和5-氟尿嘧啶联合化疗加昂丹司琼后5-羟吲哚乙酸的排泄情况。
Support Care Cancer. 1996 Sep;4(5):384-9. doi: 10.1007/BF01788846.
4
The role of serotonin as a mediator of emesis induced by different stimuli.血清素作为不同刺激诱导呕吐的介质的作用。
Support Care Cancer. 1995 Sep;3(5):285-90. doi: 10.1007/BF00335303.